Activation of ERK1/2 by extracellular nucleotides in macrophages is mediated by multiple P2 receptors independently of P2X 7-associated pore or channel formation

British Journal of Pharmacology

Volumn 147, Issue 3, 2006, Pages 324-334

  Da Cruz, Cristiane Monteiro ^a   Marques Ventura, Ana Lúcia ^b   Schachter, Julieta ^a   Costa Jr , Helio Miranda ^a   Da Silva Souza, Hercules Antonio ^a   Gomes, Fernanda Ramos ^a   Coutinho Silva, Robson ^a   Ojcius, David M ^c   Persechini, Pedro Muanis ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ATP; ERK1 2; Macrophage; MAP kinase; P2 receptor; P2X 7; Permeabilization; Pore

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADENOSINE TRIPHOSPHATE; CALCIUM ION; CHELERYTHRINE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; GENISTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NUCLEOTIDE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; PURINE P2 RECEPTOR; PURINE P2X7 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR STIMULATING AGENT; TYRPHOSTIN; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL MEMBRANE PERMEABILITY; CHANNEL GATING; CONCENTRATION (PARAMETERS); ENZYME PHOSPHORYLATION; EXPOSURE; FEMALE; MACROPHAGE; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN BINDING;

ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIUM SIGNALING; CELL MEMBRANE PERMEABILITY; ENZYME ACTIVATION; FEMALE; MACROPHAGES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C; RECEPTORS, PURINERGIC P2; RECEPTORS, PURINERGIC P2X7; SIGNAL TRANSDUCTION;

EID: 32244448895     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706559     Document Type: Article

References (63)

1. ADRIAN, K., BERNHARD, M.K., BREITINGER, H. & OGILVIE, A. (2000). Expression of purinergic receptors (ionotropic P2X1-7 and metabotropic P2Y1-11) during myeloid differentiation of HL60 cells. Biochim. Biophys. Acta. 1492, 127-138.
2. AGA, M., JOHNSON, C.J., HART, A.P., GUADARRAMA, A.G., SURESH, M., SVAREN, J., BERTICS, P.J. & DARIEN, B.J. (2002). Modulation of monocyte signaling and pore formation in response to agonists of the nucleotide receptor P2X(7). J. Leukocyte Biol., 72, 222-232.
3. ALBUQUERQUE, C., OLIVEIRA, S.M., COUTINHO-SILVA, R., OLIVEIRA-CASTRO, G.M. & PERSECHINI, P.M. (1993). ATP-and UTP-induced currents in macrophages and macrophage-polykaryons. Am. J. Physiol., 265, C1663-C1673.
4. 2+ influx. Biochem. J., 374, 51-61.
5. AUGER, R., MOTTA, I., BENIHOUD, K., OJCIUS, D.M. & KANELLO-POULOS, J.M. (2005). A role for mitogen-activated protein kinase ERK1/2 activation and non-selective pore formation in P2X7 receptor-mediated thymocyte death. J. Biol. Chem., 280, 28142-28151.
6. BEIGI, R.D., KERTESY, S.B., AQUILINA, G. & DUBYAK, G.R. (2003). Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor-independent mechanisms. Br. J. Pharmacol., 140, 507-519.
7. BISAGGIO, R.C., NIHEI, O.K., PERSECHINI, P.M., SAVINO, W. & ALVES, L.A. (2001). Characterization of P2 receptors in thymic epithelial cells. Cell. Mol. Biol., 47, 19-31.
8. BOWLER, J.W., BAILEY, R.J., NORTH, R.A. & SURPRENANT, A. (2003). P2X4, P2Y1 and P2Y2 receptors on rat alveolar macrophages. Br. J. Pharmacol., 140, 567-575.
9. BOYER, J.L., ROMERO-AVILA, T., SCHACHTER, J.B. & HARDEN, T.K. (1996). Identification of competitive antagonists of the P2Y1 receptor. Mol. Pharmacol., 50, 1323-1329.
10. BRADFORD, M.D. & SOLTOFF, S.P. (2002). P2X7 receptors activate protein kinase D and p42/p44 mitogen-activated protein kinase (MAPK) downstream of protein kinase C. Biochem. J., 366, 745-755.
11. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
12. BRONTE, V., MACINO, B., ZAMBON, A., ROSATO, A., MANDRUZZATO, S., ZANOVELLO, P. & COLLAVO, D. (1996). Protein tyrosine kinases and phosphatases control apoptosis induced by extracellular adenosine 5′-triphosphate. Biochem. Biophys. Res. Commun., 218, 344-351.
13. BURNSTOCK, G. (2002). Purinergic signaling and vascular cell proliferation and death. Arterioscler. Thromb. Vasc. Biol., 22, 364-373.
14. BURNSTOCK, G. & KNIGHT, G.E. (2004). Cellular distribution and functions of P2 receptor subtypes in different systems. Int. Rev. Citoles, 240, 31-304.
15. COUTINHO-SILVA, R., OJCIUS, D.M., GÓRECKI, D.C., PERSECHINI, P.M., BISAGGIO, R.C., MENDES, A.N., MARKES, J., BURNSTOCK, G. & DUNN, P.M. (2005). Multiple P2X and P2Y receptor subtypes in mouse J774, spleen and peritoneal macrophages. Biochem. Pharmacol., 69, 641-655.
16. COUTINHO-SILVA, R. & PERSECHINI, P.M. (1997). P2Z purinoceptor-associated pores induced by extracellular ATP in macrophages and J774 cells. Am. J. Physiol., 273, C1793-C1800.
17. COUTINHO-SILVA, R., PERSECHINI, P.M., BISAGGIO, R.C., PERFETTINI, J.-L., SÁ-NETO, A.C.T., KANELLOPOULOS, J.M., MOTTA-LY, I., DAUTRY-VARSAT, A. & OJCIUS, D.M. (1999). P2Z/P2X7 receptor-dependent apoptosis of dendritic cells. Am. J. Physiol., 276, C1139-C1147.
18. COUTINHO-SILVA, R., STAHL, L., RAYMOND, M.-N., JUNGAS, T., VERBEKE, P., BURNSTOCK, G., DARVILLE, T. & OJCIUS, D.M. (2003). Inhibition of chlamydial infectious activity due to P2X7R-dependent phospholipase D activation. Immunity, 19, 403-412.
19. DANGELMAIER, C., JIN, J., DANIEL, J.L., SMITH, J.B. & KUNAPULI, S.P. (2000). The P2Y1 receptor mediates ADP-induced p38 kinase-activating factor generation in human platelets. Eur. J. Biochem., 267, 2283-2289.
20. DENLINGER, L.C., FISETTE, P.L., SOMMER, J.A., WATTERS, J.J., PRABHU, U., DUBYAK, G.R., PROCTOR, R.A. & BERTICS, P.J. (2001). The nucleotide receptor P2X7 contains multiple protein-and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. J. Immunol., 167, 1871-1876.
21. DI VIRGILIO, F., CHIOZZI, P., FERRARI, D., FALZONI, S., SANZ, J.M., MORELLI, A., TORBOLI, M., BOLOGNESI, G. & BARICORDI, O.R. (2001). Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood, 97, 587-600.
22. DONG, C., DAVIS, R.J. & FLAVELL, R.A. (2002). MAP kinases in the immune response. Annu. Rev. Immunol., 20, 55-72.
23. DONNELLY-ROBERTS, D.L., NAMOVIC, M.T., FALTYNEK, C.R. & JARVIS, M.F. (2004). Mitogen-activated protein kinase and caspase signaling pathways are required for P2X7 receptor (P2X7R)-induced pore formation in human THP-1 cells. J. Pharmacol. Exp. Ther., 308, 1053-1061.
24. DUBYAK, G.R. & EL-MOATASSIM, C. (1993). Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol., 265, C577-C606.
25. EL-MOATASSIM, C. & DUBYAK, G.R. (1992). A novel pathway for the activation of phospholipase-D by P(2z) purinergic receptors in BAC1.2F5 macrophages. J. Biol. Chem., 267, 23664-23673.
26. FARIA, R.X., DE FARIAS, F.P. & ALVES, L.A. (2004). Are second messengers crucial for opening the pore associated with P2X7 receptor? Am. J. Physiol. Cell Physiol., 288, C260-C271.
27. GENDRON, F.P., CHALIMONIUK, M., STROSZNAJDER, J., SHEN, S., GONZALEZ, F.A., WEISMAN, G.A. & SUN, G.Y. (2003a). P2X7 nucleotide receptor activation enhances IFN gamma-induced type II nitric oxide synthase activity in BV-2 microglial cells. J. Neurochem., 87, 344-352.
28. GENDRON, F.P., NEARY, J.T., THEISS, P.M., SUN, G.Y., GONZALEZ, F.A. & WEISMAN, G.A. (2003b). Mechanisms of P2X7 receptor-mediated ERK1/2 phosphorylation in human astrocytoma cells. Am. J. Physiol. Cell Physiol., 284, C571-C581.
29. 2+ fluxes in J774 macrophages by two distinct mechanisms. J. Biol. Chem., 263, 10337-10343.
30. HAMILL, O.P., MARTY, A., NEHER, E., SAKMANN, B. & SIGWORTH, F.J. (1981). Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Eur. J. Physiol., 391, 85-100.
31. HIDE, I., TANAKA, M., INOUE, A., NAKAJIMA, K., KOHSAKA, S., INOUE, K. & NAKATA, Y. (2000). Extracellular ATP triggers tumor necrosis factor-alpha release from rat microglia. J. Neurochem., 75, 965-972.
32. HU, Y., FISETTE, P.L., DENLINGER, L.C., GUADARRAMA, A.G., SOMMER, J.A., PROCTOR, R.A. & BERTICS, P.J. (1998). Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages. J. Biol. Chem., 273, 27170-27175.
33. HUMPHREYS, B.D., RICE, J., KERTESY, S.B. & DUBYAK, G.R. (2000). Stress-activated protein kinase/JNK activation and apoptotic induction by the macrophage P2X7 nucleotide receptor. J. Biol. Chem., 275, 26792-26798.
34. HUNG, A.C. & SUN, S.H. (2002). The P2X(7) receptor-mediated phospholipase D activation is regulated by both PKC-dependent and PKC-independent pathways in a rat brain-derived type-2 astrocyte cell line, RBA-2. Cell Signal., 14, 83-92.
35. JACOBSON, K.A., KING, B.F. & BURNSTOCK, G. (2002). Pharmacological characterization of P2 (nucleotide) receptors. Cell Transm., 16, 1-23.
36. JIANG, L.H., RASSENDREN, F., MACKENZIE, A.B., ZHANG, Y.H., SURPRENANT, A. & NORTH, R.A. (2005). N-methyl-D-glucamine and propidium dyes utilize different permeation pathways at rat P2X7 receptors. Am. J. Physiol Cell Physiol., 289, C1295-C1302.
37. JIN, J.G., DASARI, V.R., SISTARE, F.D. & KUNAPULI, S.P. (1998). Distribution of P2Y receptor subtypes on haematopoietic cells. Br. J. Pharmacol., 123, 789-794.
38. KIM, M., JIANG, L.H., WILSON, H.L., NORTH, R.A. & SURPRENANT, A. (2001). Proteomic and functional evidence for a P2X(7) receptor signalling complex. EMBO J., 20, 6347-6358.
39. LAMMAS, D.A., STOBER, C., HARVEY, C.J., KENDRICK, N., PANCHALINGAM, S. & KUMARARATNE, D.S. (1997). ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity, 7, 433-444.
40. LENZ, G., GOTTFRIED, C., LUO, Z., AVRUCH, J., RODNIGHT, R., NIE, W.J., KANG, Y. & NEARY, J.T. (2000). P(2Y) purinoceptor subtypes recruit different MEK activators in astrocytes. Br. J. Pharmacol., 129, 927-936.
41. MORELLI, A., CHIOZZI, P., CHIESA, A., FERRARI, D., SANZ, J.M., FALZONI, S., PINTON, P., RIZZUTO, R., OLSON, M.F. & DI VIRGILIO, F. (2003). Extracellular ATP causes ROCK I-dependent bleb formation in P2X7-transfected HEK293 cells. Mol. Biol. Cell, 14, 2655-2664.
42. MORELLI, A., FERRARI, D., BOLOGNESI, G., RIZZUTO, R. & DI VIRGILIO, F. (2001). Proapoptotic plasma membrane pore: P2X7 receptor. Drug Dev. Res., 52, 571-578.
43. MURGIA, M., HANAU, S., PIZZO, P., RIPPA, M. & DI VIRGILIO, F. (1993). Oxidized ATP an irreversible inhibitor of macrophage purinergic P2Z receptor. J. Biol. Chem., 268, 8199-8203.
44. NAPOLITANI, G., RINALDI, A., BERTONI, F., SALLUSTO, F. & LANZAVECCHIA, A. (2005). Selected toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol., 6, 769-776.
45. NEARY, J.T., KANG, Y., BU, Y., YU, E., AKONG, K. & PETERS, C.M. (1999). Mitogenic signaling by ATP/P2Y purinergic receptors in astrocytes: involvement of a calcium-independent protein kinase C, extracellular signal-regulated protein kinase pathway distinct from the phosphatidylinositol- specific phospholipase C/calcium pathway. J. Neurosci., 19, 4211-4220.
46. NORTH, R.A. (2002). Molecular physiology of P2X receptors. Physiol. Rev., 82, 1013-1067.
47. PANENKA, W., JIJON, H., HERX, L.M., ARMSTRONG, J.N., FEIGHAN, D., WEI, T., YONG, V.W., RANSOHOFF, R.M. & MACVICAR, B.A. (2001). P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase. J. Neurosci., 21, 7135-7142.
48. PARVATHENANI, L.K., TERTYSHNIKOVA, S., GRECO, C.R., ROBERTS, S.B., ROBERTSON, B. & POSMANTUR, R. (2003). P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J. Biol. Chem., 278, 13309-13317.
49. PERSECHINI, P.M., BISAGGIO, R.C., ALVES-NETO, J.L. & COUTINHO-SILVA, R. (1998). Extracellular ATP in the lymphohematopoietic system: P2Z purinoceptors and membrane permeabilization. Braz. J. Med. Biol. Res., 31, 25-34.
50. PFEIFFER, Z.A., AGA, M., PRABHU, U., WATTERS, J.J., HALL, D.J. & BERTICS, P.J. (2004). The nucleotide receptor P2X7 mediates actin reorganization and membrane blebbing in RAW 264.7 macrophages via p38 MAP kinase and Rho. J. Leukocyte Biol., 75, 1173-1182.
51. RALEVIC, V. & BURNSTOCK, G. (1998). Receptors for purines and pyrimidines. Pharmacol. Rev., 50, 413-492.
52. SANTIAGO-PEREZ, L.I., FLORES, R.V., SANTOS-BERRIOS, C., CHORNA, N.E., KRUGH, B., GARRAD, R.C., ERB, L., WEISMAN, G.A. & GONZALEZ, F.A. (2001). P2Y(2) nucleotide receptor signaling in human monocytic cells: activation, desensitization and coupling to mitogen-activated protein kinases. J. Cell Physiol., 187, 196-208.
53. SAUNDERS, B.M., FERNANDO, S.L., SLUYTER, R., BRITTON, W.J. & WILEY, J.S. (2003). A loss-of-function polymorphism in the human P2X7 receptor abolishes ATP-mediated killing of mycobacteria. J. Immunol., 171, 5442-5446.
54. 4- permeabilizes the plasma membrane of mouse macrophages to fluorescent dyes. J. Biol. Chem., 262, 8884-8888.
55. 4- promotes cation fluxes in the J774 mouse macrophage cell line. J. Biol. Chem., 262, 3118-3122.
56. 7). Science, 272, 735-738.
57. TAKENOUCHI, T., OGIHARA, K., SATO, M. & KITANI, H. (2005). Inhibitory effects of U73122 and U73343 on Ca(2+) influx and pore formation induced by the activation of P2X7 nucleotide receptors in mouse microglial cell line. Biochim. Biophys. Acta, 1726, 177-186.
58. VARTIAN, N. & BOEHM, S. (2001). P2Y receptor-mediated inhibition of voltage-activated Ca(2+) currents in PC12 cells. Eur. J. Neurosci., 13, 899-908.
59. VERHOEF, P.A., ESTACION, M., SCHILLING, W. & DUBYAK, G.R. (2003). P2X7 receptor-dependent blebbing and the activation of Rho-effector kinases, caspases, and IL-1 beta release. J. Immunol., 170, 5728-5738.
60. VIGNE, P., HECHLER, B., GACHET, C., BREITTMAYER, J.P. & FRELIN, C. (1999). Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation. Biochem. Biophys. Res. Commun., 256, 94-97.
61. WARNY, M., ABOUDOLA, S., ROBSON, S.C., SEVIGNY, J., COMMUNI, D., SOLTOFF, S.P. & KELLY, C.P. (2001). P2Y(6) nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide. J. Biol. Chem., 276, 26051-26056.
62. WEISS, D.S., RAUPACH, B., TAKEDA, K., AKIRA, S. & ZYCHLINSKY, A. (2004). Toll-like receptors are temporally involved in host defense. J. Immunol., 172, 4463-4469.
63. 2+ response to both UTP and ATP at human P2Y11 receptors: evidence for agonist-specific signaling. Mol. Pharmacol., 63, 1356-1363.